Compare RLMD & TCBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RLMD | TCBX |
|---|---|---|
| Founded | 2004 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 524.9M | 659.5M |
| IPO Year | 2012 | 2021 |
| Metric | RLMD | TCBX |
|---|---|---|
| Price | $5.21 | $43.10 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 3 |
| Target Price | $12.40 | ★ $45.00 |
| AVG Volume (30 Days) | ★ 1.8M | 111.8K |
| Earning Date | 05-08-2026 | 04-22-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 45.28 | 36.33 |
| EPS | N/A | ★ 0.88 |
| Revenue | ★ $13,070.00 | N/A |
| Revenue This Year | N/A | $29.99 |
| Revenue Next Year | N/A | $10.14 |
| P/E Ratio | ★ N/A | $48.58 |
| Revenue Growth | ★ 154.83 | N/A |
| 52 Week Low | $0.55 | $35.60 |
| 52 Week High | $8.00 | $43.84 |
| Indicator | RLMD | TCBX |
|---|---|---|
| Relative Strength Index (RSI) | 35.70 | 62.29 |
| Support Level | $4.06 | $36.45 |
| Resistance Level | $7.28 | $43.20 |
| Average True Range (ATR) | 0.39 | 1.28 |
| MACD | -0.08 | 0.19 |
| Stochastic Oscillator | 21.49 | 80.91 |
Relmada Therapeutics Inc is a clinical-stage, publicly traded biotechnology company focused on the development of NDV-01 and sepranolone. NDV-01 is a novel, controlled-release intravesical formulation of gemcitabine and docetaxel. NDV-01 is currently in a Phase 2 clinical trial in Isreal to assess its safety and efficacy in patients with aggressive forms of non-muscle invasive bladder cancer (NMIBC). Sepranolone is a novel neurosteroid epimer of allopregnanolone. sepranolone is being developed for the potential treatment of Prader-Willi Syndrome, Tourette Syndrome, excessive tremor and other diseases related to excessive GABAergic activity.
Third Coast Bancshares Inc is a bank holding company. It focuses on providing commercial banking solutions to small and medium-sized businesses and professionals with operations in its markets. The bank operates twenty branches in the Greater Houston, Dallas-Fort Worth, and Austin-San Antonio markets, one branch in Ballinger, Texas, and one branch in Detroit, Texas. The company operates through one segment, community banking, It generates the majority of its revenue from interest on loans, customer service, and loan fees.